FMT
ALNY icon

First Mercantile Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

First Mercantile Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,947
Closed -$286K – 1081
2014
Q4 		$286K Sell
2,947
-8,975
-75% -$832K 0.02% 625
2014
Q3 		$931K Sell
11,922
-1,227
-9% -$79.1K 0.08% 350
2014
Q2 		$830K Buy
13,149
+1,585
+14% +$94.2K 0.07% 398
2014
Q1 		$776K Sell
11,564
-1,250
-10% -$96.8K 0.06% 461
2013
Q4 		$824K Sell
12,814
-4,700
-27% -$280K 0.06% 429
2013
Q3 		$1.12M Buy
17,514
+2,500
+17% +$125K 0.09% 328
2013
Q2 		$466K Buy
+15,014
New +$400K 0.04% 564

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return